WP
SNDX icon

Woodline Partners’s Syndax Pharmaceuticals SNDX Stock Holding History

Woodline Partners’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.2M Buy
1,250,760
+92
+0% +$2K 0.11% 253
2025
Q4 		$26.3M Sell
1,250,668
-299,852
-19% -$5.23M 0.1% 259
2025
Q3 		$23.9M Sell
1,550,520
-342,231
-18% -$4.48M 0.11% 244
2025
Q2 		$17.7M Buy
1,892,751
+948
+0.1% +$10.4K 0.09% 313
2025
Q1 		$23.2M Hold
1,891,803
– – 0.15% 199
2024
Q4 		$25M Sell
1,891,803
-4,229
-0.2% -$72.4K 0.17% 175
2024
Q3 		$36.5M Buy
1,896,032
+350,504
+23% +$7.24M 0.31% 101
2024
Q2 		$31.7M Buy
1,545,528
+1,241
+0.1% +$26K 0.3% 100
2024
Q1 		$36.8M Buy
1,544,287
+71
+0% +$1.58K 0.34% 88
2023
Q4 		$33.4M Buy
1,544,216
+1,510,149
+4,433% +$23.2M 0.36% 79
2023
Q3 		$495K Sell
34,067
-578,249
-94% -$10.9M 0.01% 496
2023
Q2 		$12.8M Buy
+612,316
New +$12.7M 0.15% 176
2022
Q4 		– Sell
-789,273
Closed -$19M – 837
2022
Q3 		$19M Buy
+789,273
New +$17.7M 0.27% 110
2022
Q1 		– Sell
-310,377
Closed -$6.79M – 813
2021
Q4 		$6.79M Sell
310,377
-270,931
-47% -$5.01M 0.1% 248
2021
Q3 		$11.1M Buy
581,308
+373,496
+180% +$6.22M 0.18% 148
2021
Q2 		$3.57M Buy
+207,812
New +$3.81M 0.07% 268
2021
Q1 		– Sell
-77,699
Closed -$1.73M – 471
2020
Q4 		$1.73M Buy
+77,699
New +$1.61M 0.05% 200

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Woodline Partners's SNDX Position: Q1 2026 in Review

Woodline Partners increased its Syndax Pharmaceuticals (SNDX) stake by 0.01% in Q1 2026, buying an estimated $2K and bringing the position to 1,250,760 shares worth $29.2M. The position accounts for 0.11% of the portfolio, ranked #253.

Woodline Partners first reported a position in SNDX in Q4 2020 and has held it in 17 quarters since. The position peaked at $36.8M in Q1 2024. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Woodline Partners held 1,250,760 shares of Syndax Pharmaceuticals worth $29.2M as of Q1 2026.
  • Woodline Partners bought 92 Syndax Pharmaceuticals shares in Q1 2026, an estimated $2K.
  • Syndax Pharmaceuticals made up 0.11% of Woodline Partners's portfolio in Q1 2026, its #253 holding.
  • Woodline Partners first reported a position in Syndax Pharmaceuticals in Q4 2020 and has held it in 17 quarters since.
  • Woodline Partners's Syndax Pharmaceuticals position peaked at $36.8M in Q1 2024.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.